REQUEST A DEMO
Total
USD $0.00
Search more companies

CYCLOLAB, Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: CYCLOLAB, Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

CycloLab Cyclodextrin Research & Development Laboratory specializes in the development and manufacturing of cyclodextrins for pharmaceutical, cosmetic, food, agrochemical, and environmental applications. The company offers a wide variety of cyclodextrins in various grades and provides services for novel applications of cyclodextrins. CycloLab Cyclodextrin Research & Development Laboratory operates as a CRO for cyclodextrin-related services with a staff of internationally acknowledged experts.

Headquarters
Illatos ut 7.
Budapest; Budapest; Postal Code: 1097

Contact Details: Purchase the CYCLOLAB, Kft. report to view the information.

Website: http://www.cyclolab.hu

Basic Information
Total Employees:
Purchase the CYCLOLAB, Kft. report to view the information.
Registered Capital:
Purchase the CYCLOLAB, Kft. report to view the information.
Financial Auditors:
Purchase the CYCLOLAB, Kft. report to view the information.
Incorporation Date:
December 05, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Cf Pharma Kft.
Company Performance
Financial values in the chart are available after CYCLOLAB, Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
59.42%
Total operating revenue
46.53%
Operating profit (EBIT)
-65.8%
EBITDA
-44.09%
Net Profit (Loss) for the Period
2745.24%
Total Assets
9.63%
Total Equity
31.92%
Operating Profit Margin (ROS)
-20%
Net Profit Margin
29.73%
Return on Equity (ROE)
23.07%
Quick Ratio
-0.77%
Cash Ratio
-0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?